Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: RAS genotyping is mandatory for the prescription of anti-EGFR (epidermal growth factor receptor) therapies in patients with metastatic colorectal cancer. The standard genotyping is assessed on formalin-fixed paraffin embedded tumour tissue. This study compares RAS and BRAF genotyping results achieved in analyzing circulating plasma DNA using OncoBEAM technique with those achieved using the standard genotyping techniques and formalin-fixed paraffin embedded samples.
DISEASE(S): Colorectal Neoplasms,Colorectal Cancer Metastatic
PROVIDER: 2213536 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA